Le Lézard
Classified in: Health

Media Advisory: Canadian Blood Services invites public to open board meeting Dec. 6

OTTAWA , Dec. 04, 2019 (GLOBE NEWSWIRE) --

WHAT:Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca and inviting the public to attend in person in Ottawa.
 Members of the public are invited to participate in open board meetings twice each year to hear about the organization's work, deliver presentations and meet with members of the board and the management team.
 Since its inception in 1998, Canadian Blood Services has been committed to operating in an open, transparent and collaborative manner.
WHO: Dr. Graham Sher, CEO, Canadian Blood Services, and members of the Executive Management Team
 Mel Cappe, Chair of the Board of Directors and members of the Board of Directors
WHEN:Friday, Dec. 6, 2019
 8:30 a.m. to 12:30 p.m. EST
WHERE: Canadian Blood Services
 1800 Alta Vista Drive
 Ottawa, ON
 Live stream available at https://blood.ca/en/about-us/governance/board-meetings/next-open-board-meeting

About Canadian Blood Services
Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians.

1 888 2DONATE

For more information:
Tel. 1-877-709-7773

These press releases may also interest you

at 00:21
Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional...

at 00:01
Sacrificing one's health to vote in the November election: 60% are willing to risk their health to vote in person, according to the latest healthinsurance.com consumer pulse survey. 63% of Americans don't think healthcare should be a political issue....

at 00:00
45% of global consumers say healthcare is one of the top three reasons for living in a city 69% of global consumers are more focused on mental health and well being 43% of global consumer expect businesses to be accountable for their environmental...

at 00:00
R3 International is now offering effective stem cell therapy for Crohns disease, Ulcerative Colitis and IBD with a new program in Mexico. The new program provides up to 200 million stem cells for patients, with treatment starting at only $2975....

7 jui 2020
Astex Pharmaceuticals, Inc.; Taiho Oncology, Inc.; and Otsuka Pharmaceutical Co., Ltd. today announce that the U.S. Food and Drug Administration (FDA) and Health Canada have approved INQOVI® (decitabine and cedazuridine) tablets. The three companies...

7 jui 2020
Note: All times local Ottawa, Ontario Private meetings. 11:00 a.m. The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow. Room 225 West Block Parliament Hill Notes for media: Open coverage Media...

News published on 4 december 2019 at 19:20 and distributed by: